Non Insulin Anti diabetes Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 69 pages | ID: NC91C4029F2EEN
Market Monitor Global

Abstracts

Diabetes is a metabolic disease, wherein the body is either unable to secret insulin (type 1 diabetes) or is unable to utilize the generated insulin (type 2 diabetes).

This report contains market size and forecasts of Non Insulin Anti diabetes Drugs in Global, including the following market information:

Global Non Insulin Anti diabetes Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Non Insulin Anti diabetes Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Non Insulin Anti diabetes Drugs include Sanofi, Abbott, AstraZeneca, Eli Lilly, Roche, GlaxoSmithKline, Johnson & Johnson and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non Insulin Anti diabetes Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Non Insulin Anti diabetes Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Non Insulin Anti diabetes Drugs Market Segment Percentages, by Type, 2021 (%)

• Oral Drugs
• Injectable Drugs

Global Non Insulin Anti diabetes Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Non Insulin Anti diabetes Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Non Insulin Anti diabetes Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Non Insulin Anti diabetes Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Non Insulin Anti diabetes Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Non Insulin Anti diabetes Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Abbott
• AstraZeneca
• Eli Lilly
• Roche
• GlaxoSmithKline
• Johnson & Johnson
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Non Insulin Anti diabetes Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Non Insulin Anti diabetes Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NON INSULIN ANTI DIABETES DRUGS OVERALL MARKET SIZE

2.1 Global Non Insulin Anti diabetes Drugs Market Size: 2021 VS 2028
2.2 Global Non Insulin Anti diabetes Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Non Insulin Anti diabetes Drugs Players in Global Market
3.2 Top Global Non Insulin Anti diabetes Drugs Companies Ranked by Revenue
3.3 Global Non Insulin Anti diabetes Drugs Revenue by Companies
3.4 Top 3 and Top 5 Non Insulin Anti diabetes Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Non Insulin Anti diabetes Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non Insulin Anti diabetes Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Non Insulin Anti diabetes Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Non Insulin Anti diabetes Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Non Insulin Anti diabetes Drugs Market Size Markets, 2021 & 2028
  4.1.2 Oral Drugs
  4.1.3 Injectable Drugs
4.2 By Type - Global Non Insulin Anti diabetes Drugs Revenue & Forecasts
  4.2.1 By Type - Global Non Insulin Anti diabetes Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Non Insulin Anti diabetes Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Non Insulin Anti diabetes Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Non Insulin Anti diabetes Drugs Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Non Insulin Anti diabetes Drugs Revenue & Forecasts
  5.2.1 By Application - Global Non Insulin Anti diabetes Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Non Insulin Anti diabetes Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Non Insulin Anti diabetes Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Non Insulin Anti diabetes Drugs Market Size, 2021 & 2028
6.2 By Region - Global Non Insulin Anti diabetes Drugs Revenue & Forecasts
  6.2.1 By Region - Global Non Insulin Anti diabetes Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Non Insulin Anti diabetes Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Non Insulin Anti diabetes Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Non Insulin Anti diabetes Drugs Revenue, 2017-2028
  6.3.2 US Non Insulin Anti diabetes Drugs Market Size, 2017-2028
  6.3.3 Canada Non Insulin Anti diabetes Drugs Market Size, 2017-2028
  6.3.4 Mexico Non Insulin Anti diabetes Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Non Insulin Anti diabetes Drugs Revenue, 2017-2028
  6.4.2 Germany Non Insulin Anti diabetes Drugs Market Size, 2017-2028
  6.4.3 France Non Insulin Anti diabetes Drugs Market Size, 2017-2028
  6.4.4 U.K. Non Insulin Anti diabetes Drugs Market Size, 2017-2028
  6.4.5 Italy Non Insulin Anti diabetes Drugs Market Size, 2017-2028
  6.4.6 Russia Non Insulin Anti diabetes Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Non Insulin Anti diabetes Drugs Market Size, 2017-2028
  6.4.8 Benelux Non Insulin Anti diabetes Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Non Insulin Anti diabetes Drugs Revenue, 2017-2028
  6.5.2 China Non Insulin Anti diabetes Drugs Market Size, 2017-2028
  6.5.3 Japan Non Insulin Anti diabetes Drugs Market Size, 2017-2028
  6.5.4 South Korea Non Insulin Anti diabetes Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Non Insulin Anti diabetes Drugs Market Size, 2017-2028
  6.5.6 India Non Insulin Anti diabetes Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Non Insulin Anti diabetes Drugs Revenue, 2017-2028
  6.6.2 Brazil Non Insulin Anti diabetes Drugs Market Size, 2017-2028
  6.6.3 Argentina Non Insulin Anti diabetes Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Non Insulin Anti diabetes Drugs Revenue, 2017-2028
  6.7.2 Turkey Non Insulin Anti diabetes Drugs Market Size, 2017-2028
  6.7.3 Israel Non Insulin Anti diabetes Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Non Insulin Anti diabetes Drugs Market Size, 2017-2028
  6.7.5 UAE Non Insulin Anti diabetes Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Non Insulin Anti diabetes Drugs Major Product Offerings
  7.1.4 Sanofi Non Insulin Anti diabetes Drugs Revenue in Global Market (2017-2022)
  7.1.5 Sanofi Key News
7.2 Abbott
  7.2.1 Abbott Corporate Summary
  7.2.2 Abbott Business Overview
  7.2.3 Abbott Non Insulin Anti diabetes Drugs Major Product Offerings
  7.2.4 Abbott Non Insulin Anti diabetes Drugs Revenue in Global Market (2017-2022)
  7.2.5 Abbott Key News
7.3 AstraZeneca
  7.3.1 AstraZeneca Corporate Summary
  7.3.2 AstraZeneca Business Overview
  7.3.3 AstraZeneca Non Insulin Anti diabetes Drugs Major Product Offerings
  7.3.4 AstraZeneca Non Insulin Anti diabetes Drugs Revenue in Global Market (2017-2022)
  7.3.5 AstraZeneca Key News
7.4 Eli Lilly
  7.4.1 Eli Lilly Corporate Summary
  7.4.2 Eli Lilly Business Overview
  7.4.3 Eli Lilly Non Insulin Anti diabetes Drugs Major Product Offerings
  7.4.4 Eli Lilly Non Insulin Anti diabetes Drugs Revenue in Global Market (2017-2022)
  7.4.5 Eli Lilly Key News
7.5 Roche
  7.5.1 Roche Corporate Summary
  7.5.2 Roche Business Overview
  7.5.3 Roche Non Insulin Anti diabetes Drugs Major Product Offerings
  7.5.4 Roche Non Insulin Anti diabetes Drugs Revenue in Global Market (2017-2022)
  7.5.5 Roche Key News
7.6 GlaxoSmithKline
  7.6.1 GlaxoSmithKline Corporate Summary
  7.6.2 GlaxoSmithKline Business Overview
  7.6.3 GlaxoSmithKline Non Insulin Anti diabetes Drugs Major Product Offerings
  7.6.4 GlaxoSmithKline Non Insulin Anti diabetes Drugs Revenue in Global Market (2017-2022)
  7.6.5 GlaxoSmithKline Key News
7.7 Johnson & Johnson
  7.7.1 Johnson & Johnson Corporate Summary
  7.7.2 Johnson & Johnson Business Overview
  7.7.3 Johnson & Johnson Non Insulin Anti diabetes Drugs Major Product Offerings
  7.7.4 Johnson & Johnson Non Insulin Anti diabetes Drugs Revenue in Global Market (2017-2022)
  7.7.5 Johnson & Johnson Key News
7.8 Novartis
  7.8.1 Novartis Corporate Summary
  7.8.2 Novartis Business Overview
  7.8.3 Novartis Non Insulin Anti diabetes Drugs Major Product Offerings
  7.8.4 Novartis Non Insulin Anti diabetes Drugs Revenue in Global Market (2017-2022)
  7.8.5 Novartis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Non Insulin Anti diabetes Drugs Market Opportunities & Trends in Global Market
Table 2. Non Insulin Anti diabetes Drugs Market Drivers in Global Market
Table 3. Non Insulin Anti diabetes Drugs Market Restraints in Global Market
Table 4. Key Players of Non Insulin Anti diabetes Drugs in Global Market
Table 5. Top Non Insulin Anti diabetes Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Non Insulin Anti diabetes Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Non Insulin Anti diabetes Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Non Insulin Anti diabetes Drugs Product Type
Table 9. List of Global Tier 1 Non Insulin Anti diabetes Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non Insulin Anti diabetes Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Non Insulin Anti diabetes Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Non Insulin Anti diabetes Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Non Insulin Anti diabetes Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Non Insulin Anti diabetes Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Non Insulin Anti diabetes Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Non Insulin Anti diabetes Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Non Insulin Anti diabetes Drugs Product Offerings
Table 32. Sanofi Non Insulin Anti diabetes Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Corporate Summary
Table 34. Abbott Non Insulin Anti diabetes Drugs Product Offerings
Table 35. Abbott Non Insulin Anti diabetes Drugs Revenue (US$, Mn), (2017-2022)
Table 36. AstraZeneca Corporate Summary
Table 37. AstraZeneca Non Insulin Anti diabetes Drugs Product Offerings
Table 38. AstraZeneca Non Insulin Anti diabetes Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Eli Lilly Corporate Summary
Table 40. Eli Lilly Non Insulin Anti diabetes Drugs Product Offerings
Table 41. Eli Lilly Non Insulin Anti diabetes Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Non Insulin Anti diabetes Drugs Product Offerings
Table 44. Roche Non Insulin Anti diabetes Drugs Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline Non Insulin Anti diabetes Drugs Product Offerings
Table 47. GlaxoSmithKline Non Insulin Anti diabetes Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Johnson & Johnson Corporate Summary
Table 49. Johnson & Johnson Non Insulin Anti diabetes Drugs Product Offerings
Table 50. Johnson & Johnson Non Insulin Anti diabetes Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Novartis Corporate Summary
Table 52. Novartis Non Insulin Anti diabetes Drugs Product Offerings
Table 53. Novartis Non Insulin Anti diabetes Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Non Insulin Anti diabetes Drugs Segment by Type in 2021
Figure 2. Non Insulin Anti diabetes Drugs Segment by Application in 2021
Figure 3. Global Non Insulin Anti diabetes Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Non Insulin Anti diabetes Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Non Insulin Anti diabetes Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non Insulin Anti diabetes Drugs Revenue in 2021
Figure 8. By Type - Global Non Insulin Anti diabetes Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Non Insulin Anti diabetes Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Non Insulin Anti diabetes Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Non Insulin Anti diabetes Drugs Revenue Market Share, 2017-2028
Figure 12. US Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Non Insulin Anti diabetes Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Non Insulin Anti diabetes Drugs Revenue Market Share, 2017-2028
Figure 24. China Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Non Insulin Anti diabetes Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Non Insulin Anti diabetes Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Non Insulin Anti diabetes Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Non Insulin Anti diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Non Insulin Anti diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AstraZeneca Non Insulin Anti diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eli Lilly Non Insulin Anti diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Non Insulin Anti diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Non Insulin Anti diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Johnson & Johnson Non Insulin Anti diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis Non Insulin Anti diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)